Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.

BACKGROUND:The incidence of multiple sclerosis (MS) is rising in women. OBJECTIVE:To determine whether the use of combined oral contraceptives (COCs) are associated with MS risk and whether this varies by progestin content. METHODS:We conducted a nested case-control study of females ages 14-48 years...

Full description

Bibliographic Details
Main Authors: Kerstin Hellwig, Lie H Chen, Frank Z Stancyzk, Annette M Langer-Gould
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4780760?pdf=render